Trade Summary

3 days ago, Vivaldi Coelho Rogerio, serving as Dir at Crinetics Pharmaceuticals, Inc. (CRNX), sold 5,000 shares at $36.15 per share, for a total transaction value of $180,761.00. Following this transaction, Vivaldi Coelho Rogerio now holds 16,300 shares of CRNX.

This sale represents a 23.00% decrease in Vivaldi Coelho Rogerio's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, March 12, 2026 and publicly disclosed via SEC Form 4 filing on Friday, March 13, 2026, 1 day after the trade was made.

Crinetics Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.